ESSA Pharma Stock Forward View

ESSA Pharma Additional Predictive Modules

Most predictive techniques to examine ESSA price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ESSA using various technical indicators. When you analyze ESSA charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur. A naive forecasting model for ESSA Pharma is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of ESSA Pharma value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

ESSA Pharma Naive Prediction Price Forecast For the 22nd of February

Given 90 days horizon, the Naive Prediction forecasted value of ESSA Pharma on the next trading day is expected to be -0.26 with a mean absolute deviation of 0.17, mean absolute percentage error of 0.06, and the sum of the absolute errors of 10.65.

ESSA Pharma Stock Forecast Pattern

Backtest ESSA Pharma

ESSA Pharma Price Prediction

Research Analysis

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of ESSA Pharma stock data series using in forecasting. Note that when a statistical model is used to represent ESSA Pharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality. This model is not at all useful as a medium-long range forecasting tool of ESSA Pharma. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict ESSA Pharma. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for ESSA Pharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ESSA Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.20 0.20 0.20 Details

Intrinsic Valuation Low Real High 0.19 0.19 0.22 Details

Bollinger Band Projection (param) Low Middle High 0.02 0.20 0.38 Details

ESSA Pharma After-Hype Price Density Analysis

ESSA Pharma Estimiated After-Hype Price Volatility

ESSA Pharma Stock Price Outlook Analysis

Notes

ESSA Pharma Hype Timeline

ESSA Pharma is currently traded for 0.20. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. ESSA is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on ESSA Pharma is about 0.0%, with the expected price after the next announcement by competition of 0.20. About 74.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.09. Some equities with similar Price to Book (P/B) outperform the market in the long run. ESSA Pharma recorded a loss per share of 0.57. The entity last dividend was issued on the 25th of August 2025. The firm had 1:20 split on the 25th of April 2018. Given the investment horizon of 90 days the next forecasted press release will be in about 3 days. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

ESSA Pharma Related Hype Analysis

ESSA Pharma Related Equities

Risk & Return

Correlation

ESSA Pharma Market Strength Events

ESSA Pharma Risk Indicators

Story Coverage note for ESSA Pharma

ESSA Pharma Short Properties

Other Consideration for investing in ESSA Stock